Aspirin and ibuprofen may significantly reduce the risk of esophageal cancers among people with Barrett’s esophagus Aspirin and other non-steroidal anti – inflammatory drugs, such as for example ibuprofen, may significantly decrease the risk of esophageal cancer among people with Barrett’s esophagus, a precancerous condition connected with chronic acid reflux that affects around 1 million to 2 million Americans dysfunction more info . These findings, by Thomas L. Vaughan, M.D., M.P.H., and co-workers at Fred Hutchinson Tumor Research Center, appear in the web edition of The Lancet Oncology. Experts at Virginia Mason INFIRMARY in Seattle and The Brigham and Women’s Medical center and Harvard Medical School in Boston also collaborated on the analysis, which was funded by the National Institutes of Wellness.

Goldstein, MD, a neurologist at Duke University and the Duke Center for Cerebrovascular Disease in addition to a fellow of the AAN, wrote, Regardless of the lack of demonstrable increased threat of recurrent intracranial bleeding in patients treated with platelet antiaggregants in this cohort, it really is uncertain whether the sufferers benefited from these medications also. Until extra data become available, the use of antiplatelet drugs in this setting should be restricted to highly selected individuals with a compelling indication and a comparatively low risk of recurrent hemorrhage.

Other Articles From "cardiology":

Random Articles